Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Significant Decline in Short Interest

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 462,700 shares, a decrease of 30.0% from the October 31st total of 661,200 shares. Approximately 2.7% of the company's stock are sold short. Based on an average daily trading volume, of 198,500 shares, the short-interest ratio is currently 2.3 days.